IVF USA Wins 'Best Medical and Health Services Brand'

2023-09-04 20:04:42，visits： 564

On December 11th, the 16th Asia-Pacific Wealth Management and Private Banking Annual Conference was grandly held in Shanghai. With the theme "Professional Shaping Value, Winning Long-Term Advantages in Times of Change," this summit discussed and exchanged ideas on how to adhere to the essence during market transformation, innovate with determination, grasp opportunities for development and adjustment, build long-term advantages, and promote the positive development of the wealth management industry. The lineup of keynote speakers for this summit was strong, bringing profound insights and outlooks from their respective industries. Over 300 executives and professionals from government, associations, private banks, wealth management companies, trusts, securities firms, asset management platforms, financial technology companies, and other enterprises gathered together to participate in this event.

"A Speech on Wealth, Family, and Succession"

For the new wealthy class, family legacy holds equal importance as financial planning. Accumulating wealth extends beyond financial resources; it involves the prosperity of the family and the harmony within it. Only with a thriving family, characterized by numerous children and a harmonious atmosphere, can there be more vigorous development. The key lies in continuing the family legacy and passing down the wealth. Based on this shared objective and values, Dr. Nathan Zhang, the founder of IVF USA, an expert in the field of assisted reproductive technology, and a holder of a medical doctorate from the United States, was invited to attend the Asia-Pacific Wealth Management and Private Banking Annual Conference, where he delivered a unique speech.

The speech revolved around the theme of "Wealth, Family, and Succession," focusing on a new approach to overseas asset allocation – overseas medical services, specifically assisted reproductive technology, and its role in enhancing family happiness.

China's population growth has entered a critical phase, with economists and policymakers viewing the declining birth rate as a "crisis." The loss of demographic dividends significantly impacts the Chinese economy. The shortage of labor force and the resulting structural effects on industries will transform into economic pressures and crises, highlighting the immense public value of childbirth. The government has recognized the seriousness of this issue and opened up the policy to allow couples to have a second child in the past few years. However, decades of family planning policies and a range of issues stemming from modern society have hindered a positive trend in birth rates. This is primarily due to the current societal conditions and shifts in people's attitudes, leading to a situation where those who can bear children are reluctant to do so, while those who want to face difficulties conceiving.

Apart from these societal issues, Dr. Nathan Zhang discussed the most significant challenge faced by the second-child policy: the decline in ovarian quality among women. Research data shows that for women under 35 years old, the live birth rate from fresh embryo transfer in in vitro fertilization (IVF) cycles is 39.6%. However, this success rate progressively declines with age. By the age of 41, the success rate drops to 11.5%, and for women aged 43-44, it's merely 5.4%. The primary reason for the low success rate in IVF procedures lies in the significant decline in the quality of reproductive cells after the age of 35. As women age, the chances of DNA and chromosomal mutations in reproductive cells increase, leading to lower pregnancy rates and higher miscarriage rates. Even if a successful pregnancy occurs, the likelihood of birth defects also rises.

Dr. Nathan Zhang recommends that young individuals who have the capability but are not ready for parenthood, or those planning to delay childbirth until later stages, should consider preserving their fertility through sperm or egg freezing. Older women are advised to freeze embryos to maintain high-quality genetic material for future use. Ideally, these fertility preservation measures should be completed before the age of 35.

"U.S. IVF Helps Chinese Families Achieve Happiness Through Multiple Children"

The reason IVF USA chose to share the topic of egg freezing and IVF (In Vitro Fertilization) in the United States is because China is taking the path of general medical care. While private hospitals may offer better service quality, they often lack access to cutting-edge medical technologies. Third-generation IVF technology is not yet widely available domestically. National regulations only permit married couples facing infertility and specific medical conditions to undergo egg freezing and IVF. Commercial egg freezing and other practices are not allowed, leading to an overall lower success rate for IVF in China.

In contrast, the United States not only possesses advanced technologies but also boasts comprehensive regulations, sophisticated equipment, and a high success rate. Moreover, it has accumulated invaluable practical experience over the years. U.S. IVF employs third-generation IVF techniques like Preimplantation Genetic Screening (PGS) and Preimplantation Genetic Diagnosis (PGD) to analyze the number and structure of embryos' chromosomes, thereby identifying and eliminating embryos with chromosomal abnormalities or genetic diseases. Embryos subjected to these screenings can achieve success rates of up to 60%-70% after transplantation at top U.S. clinics.

In the field of assisted reproduction, IVF USA has cultivated its expertise for a decade, building a strong reputation through its services and amassing thousands of successful cases. As a result, at the award ceremony of the 16th Asia-Pacific Wealth Management and Private Banking Annual Conference, IVF USA was honored with the Best Medical and Health Services Brand award. Looking ahead, IVF USA aspires to assist even more individuals in need, helping them realize their dreams of happiness through technologies like U.S. egg freezing and IVF.